Topics
COTY INC. $4.16 is a hold. The company (New York symbol COTY; Consumer sector; Shares outstanding: 873.9 million; Market cap: $3.6 billion; Dividend suspended in 2020; Takeover Target Rating: Medium; www.coty.com) is a leading maker of beauty and cosmetics products. Its main brands include CoverGirl, Max Factor, and Sally Hansen.


Due to strong competition from lower-cost brands, Coty is now exploring the sale (or spinoff) of its mass color cosmetics portfolio, which includes brands such as CoverGirl, Rimmel, Sally Hansen and Max Factor. Those products have annual sales of $1.2 billion, or about 20% of Coty’s total sales. The company is also considering selling its Brazilian operations, which generate annuals sales of $400 million.
PERFORMANCE FOOD GROUP CO. $101 is a hold. The company (New York symbol PFGC; Consumer sector; Shares outstanding: 156.5 million; Market cap: $15.8 billion; No dividend paid; Takeover Target Rating: Medium; www.pfgc.com) distributes more than 250,000 food and food-related products in North America from 155 distribution centres to over 300,000 customers in the food-away-from-home industry.


The company is now discussing a potential merger with rival US Foods Holding Co. (New York symbol USFD).
Shares of these two entertainment companies are still below their pre-pandemic levels. That has attracted activist investors who aim to spur their stock prices with asset sales or spinoffs. Even so, we feel both offer limited prospects.


CINEPLEX INC. $12 is a hold. The company (Toronto symbol CGX; Consumer sector; Shares outstanding: 63.4 million; Market cap: $760.8 million; Dividend suspended in March 2020; Takeover Target Rating: Medium; www.cineplex.com) is Canada’s largest operator of movie theatres with 155 locations (1,607 screens). It also operates 16 location-based entertainment venues in seven provinces.
Corteva took its current form when the old DowDuPont spun it off as part of the three-way breakup of its operations.


On June 1, 2019, DowDuPont investors received one Corteva share for every three shares they held. Since the spinoff, Corteva’s shares have jumped 118%.



Corteva now plans to split its seeds and chemical operations into two separate, publicly traded firms.

JOHNSON & JOHNSON $193 is a spinoff buy. The company (New York symbol JNJ; Manufacturing sector; Shares outstanding: 2.4 billion; Market cap: $463.2 billion; Dividend yield: 2.7%; Takeover Target Rating: Medium; www.jnj.com) sold shares of its consumer drug business, Kenvue Inc. (New York symbol KVUE), in May 2023 to the public at $22.00 a share. It later let its own shareholders exchange JNJ shares for Kenvue shares at a 7% discount.


The company now plans a second spinoff—its Orthopaedics business. Called DePuy Synthes, it makes hip, knee, and shoulder implants as well as surgical instruments. Its 2024 sales of $9.2 billion represented 10% of Johnson & Johnson’s total revenue. The company will probably complete the transaction in early 2027.
Diversified manufacturing firm Honeywell now plans to break up into three new companies. That follows pressure from activist investor Elliott Investment Management, which owns $5 billion of Honeywell’s shares.


The first of those spinoffs is Solstice (see next page), which makes chemicals for a variety of industrial products. It will begin trading in early November.



Honeywell now expects to complete the breakup of its automation and aerospace operations in 2026.
A: Signet Jewelers Ltd., $106.58, symbol SIG on New York (Shares outstanding: 41.0 million; Market cap: $4.0 billion; www.signetjewelers.com), is the world’s largest retailer of diamond jewellery.


The company operates roughly 2,623 stores, most under the names Kay Jewelers, Zales, Jared, Banter by Piercing Pagoda, Diamonds Direct, JamesAllen.com, Rocksbox, Peoples Jewellers, H. Samuel, and Ernest Jones.



In September 2022, Signet completed its acquisition of Seattle-based Blue Nile for $360 million. Blue Nile is a leading online retailer of engagement rings, wedding rings and fine jewellery.
A: Crombie Real Estate Investment Trust, $15.32, symbol CRR.UN on Toronto (Units outstanding: 109.6 million; Market cap: $2.9 billion; www.crombie.ca), owns, runs, and develops real estate assets.


This REIT has 306 properties making up about 8.8 million square feet. Retail properties account for 79.4% of that square footage, followed by retail-related industrial at 13.1%, office, 4.3%, and mixed-use residential, 3.2%.



Crombie’s occupancy rate is a high 97.2%.
A: The Cooper Companies Inc., $75.28, symbol COO on Nasdaq (Shares outstanding: 198.8 million; Market cap: $13.7 billion; www.coopercos.com), is a California-based healthcare business with two operating segments.


The first segment is Cooper Vision (67% of revenues); it makes and sells soft contact lenses for the vision-correction market worldwide. Cooper Vision specializes in lenses for common eye conditions like astigmatism, presbyopia, myopia, and ocular dryness.



The second segment, Cooper Surgical (33%), focuses on fertility and women’s health. It develops and markets the medical devices, diagnostic products and surgical instruments used by gynecologists and obstetricians.



Over the years, Cooper has expanded significantly through acquisitions.